Skip to main content
Log in

Genetic findings of Cypriot spinal muscular atrophy patients

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive, neurodegenerative disorder characterised commonly by proximal muscle weakness and wasting in the absence of sensory signs. Deletion or disruption of the SMN1 gene causes the disease. The SMN1 gene is located within an inverted duplication on chromosome 5q13 with the genes SMN2, NAIP and GTF2H2. MLPA analysis of 13 Cypriot SMA patients revealed that, 12 patients carried a homozygous SMN1 gene deletion and one patient carried two copies of the SMN1 gene. Two of 13 cases were a consequence of a paternally originating de novo mutation. Five genotypes were identified within the population, with the most frequent being a homozygous SMN1 and NAIP genes deletion. In conclusion, genotype–phenotype correlation revealed that SMN2 is inversely related to disease severity and that NAIP and GTF2H2 act as negative modifiers. This study provided, for the first time, a comprehensive overview of gene copy numbers and inheritance patterns within Cypriot SMA families.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ogino S, Wilson RB, Gold B (2004) New insights on the evolution of the SMN1 and SMN2 region: simulation and meta-analysis for allele and haplotype frequency calculations. Eur J Hum Genet 12(12):1015–1023. doi:10.1038/sj.ejhg.5201288

    Article  CAS  PubMed  Google Scholar 

  2. Markowitz JA, Singh P, Darras BT (2012) Spinal muscular atrophy: a clinical and research update. Pediatr Neurol 46(1):1–12. doi:10.1016/j.pediatrneurol.2011.09.001

    Article  PubMed  Google Scholar 

  3. D’Amico A, Mercuri E, Tiziano FD, Bertini E (2011) Spinal muscular atrophy. Orphanet J Rare Dis 6:71. doi:10.1186/1750-1172-6-71

    Article  PubMed Central  PubMed  Google Scholar 

  4. Prior TW, Krainer AR, Hua Y, Swoboda KJ, Snyder PC, Bridgeman SJ, Burghes AH, Kissel JT (2009) A positive modifier of spinal muscular atrophy in the SMN2 gene. Am J Hum Genet 85(3):408–413. doi:10.1016/j.ajhg.2009.08.002

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Clermont O, Burlet P, Burglen L, Lefebvre S, Pascal F, McPherson J, Wasmuth JJ, Cohen D, Le Paslier D, Weissenbach J et al (1994) Use of genetic and physical mapping to locate the spinal muscular atrophy locus between two new highly polymorphic DNA markers. Am J Hum Genet 54(4):687–694

    PubMed Central  CAS  PubMed  Google Scholar 

  6. Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M et al (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80(1):155–165

    Article  CAS  PubMed  Google Scholar 

  7. Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, McPherson JD (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 8(7):1177–1183

    Article  CAS  PubMed  Google Scholar 

  8. Lorson CL, Hahnen E, Androphy EJ, Wirth B (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 96(11):6307–6311

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B (2002) Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 70(2):358–368. doi:10.1086/338627

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Cusco I, Lopez E, Soler-Botija C, Jesus Barcelo M, Baiget M, Tizzano EF (2003) A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene. Hum Mutat 22(2):136–143. doi:10.1002/humu.10245

    Article  CAS  PubMed  Google Scholar 

  12. Kirwin SM, Vinette KM, Gonzalez IL, Abdulwahed HA, Al-Sannaa N, Funanage VL (2013) A homozygous double mutation in SMN1: a complicated genetic diagnosis of SMA. Mol Genet Genomic Med 1(2):113–117. doi:10.1002/mgg3.10

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Wirth B, Brichta L, Hahnen E (2006) Spinal muscular atrophy: from gene to therapy. Semin Pediatr Neurol 13(2):121–131. doi:10.1016/j.spen.2006.06.008

    Article  PubMed  Google Scholar 

  14. Wirth B, Schmidt T, Hahnen E, Rudnik-Schoneborn S, Krawczak M, Muller-Myhsok B, Schonling J, Zerres K (1997) De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling. Am J Hum Genet 61(5):1102–1111. doi:10.1086/301608

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Arkblad EL, Darin N, Berg K, Kimber E, Brandberg G, Lindberg C, Holmberg E, Tulinius M, Nordling M (2006) Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy. Neuromuscul Disord 16(12):830–838. doi:10.1016/j.nmd.2006.08.011

    Article  PubMed  Google Scholar 

  16. Rodrigues NR, Owen N, Talbot K, Patel S, Muntoni F, Ignatius J, Dubowitz V, Davies KE (1996) Gene deletions in spinal muscular atrophy. J Med Genet 33(2):93–96

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Amara A, Adala L, Ben Charfeddine I, Mamai O, Mili A, Lazreg TB, H’Mida D, Amri F, Salem N, Boughammura L, Saad A, Gribaa M (2012) Correlation of SMN2, NAIP, p44, H4F5 and Occludin genes copy number with spinal muscular atrophy phenotype in Tunisian patients. Eur J Paediatr Neurol 16(2):167–174. doi:10.1016/j.ejpn.2011.07.007

    Article  PubMed  Google Scholar 

  18. Burlet P, Burglen L, Clermont O, Lefebvre S, Viollet L, Munnich A, Melki J (1996) Large scale deletions of the 5q13 region are specific to Werdnig–Hoffmann disease. J Med Genet 33(4):281–283

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Derakhshandeh-Peykar P, Esmaili M, Ousati-Ashtiani Z, Rahmani M, Babrzadeh F, Farshidi S, Attaran E, Sajedifar MM, Farhud DD (2007) Molecular analysis of the SMN1 and NAIP genes in Iranian patients with spinal muscular atrophy. Ann Acad Med Singapore 36(11):937–941

    PubMed  Google Scholar 

  20. Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R, Baird S, Besner-Johnston A, Lefebvre C, Kang X et al (1995) The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80(1):167–178

    Article  CAS  PubMed  Google Scholar 

  21. Savas S, Gokgoz N, Kayserili H, Ozkinay F, Yuksel-Apak M, Kirdar B (2000) Screening of deletions in SMN, NAIP and BTF2p44 genes in Turkish spinal muscular atrophy patients. Hum Hered 50(3):162–165. doi:10.1159/000022907

    Article  CAS  PubMed  Google Scholar 

  22. Watihayati MS, Zabidi AM, Tang TH, Nishio H, Zilfalil BA (2007) NAIP-deletion analysis in Malaysian patients with spinal muscular atrophy. Kobe J Med Sci 53(4):171–175

    CAS  PubMed  Google Scholar 

  23. Jordanova A, Stoyanova V, Uzunova M, Litvinenko I, Kremensky I (1998) Deletion analysis of Bulgarian SMA families. Hum Mutat 12(1):33–38. doi:10.1002/(SICI)1098-1004(1998)12:1<33:AID-HUMU5>3.0.CO;2-Y

    Article  CAS  PubMed  Google Scholar 

  24. Miskovic M, Lalic T, Radivojevic D, Cirkovic S, Vlahovic G, Zamurovic D, Guc-Scekic M (2011) Lower incidence of deletions in the survival of motor neuron gene and the neuronal apoptosis inhibitory protein gene in children with spinal muscular atrophy from Serbia. Tohoku J Exp Med 225(3):153–159

    Article  PubMed  Google Scholar 

  25. Sertic J, Barisic N, Sostarko M, Bosnjak N, Culic V, Cvitanovic L, Ferencak G, Brzovic Z, Stavljenic-Rukavina A (1997) Deletions in the SMN and NAIP genes in patients with spinal muscular atrophy in Croatia. Coll Antropol 21(2):487–492

    CAS  PubMed  Google Scholar 

  26. Burglen L, Seroz T, Miniou P, Lefebvre S, Burlet P, Munnich A, Pequignot EV, Egly JM, Melki J (1997) The gene encoding p44, a subunit of the transcription factor TFIIH, is involved in large-scale deletions associated with Werdnig–Hoffmann disease. Am J Hum Genet 60(1):72–79

    PubMed Central  CAS  PubMed  Google Scholar 

  27. He J, Zhang QJ, Lin QF, Chen YF, Lin XZ, Lin MT, Murong SX, Wang N, Chen WJ (2013) Molecular analysis of SMN1, SMN2, NAIP, GTF2H2, and H4F5 genes in 157 Chinese patients with spinal muscular atrophy. Gene 518(2):325–329. doi:10.1016/j.gene.2012.12.109

    Article  CAS  PubMed  Google Scholar 

  28. Chen WJ, He J, Zhang QJ, Lin QF, Chen YF, Lin XZ, Lin MT, Murong SX, Wang N (2012) Modification of phenotype by SMN2 copy numbers in two Chinese families with SMN1 deletion in two continuous generations. Clin Chim Acta 413(23–24):1855–1860. doi:10.1016/j.cca.2012.07.020

    Article  CAS  PubMed  Google Scholar 

  29. Jedrzejowska M, Milewski M, Zimowski J, Borkowska J, Kostera-Pruszczyk A, Sielska D, Jurek M, Hausmanowa-Petrusewicz I (2009) Phenotype modifiers of spinal muscular atrophy: the number of SMN2 gene copies, deletion in the NAIP gene and probably gender influence the course of the disease. Acta Biochim Pol 56(1):103–108

    CAS  PubMed  Google Scholar 

  30. Vezain M, Saugier-Veber P, Goina E, Touraine R, Manel V, Toutain A, Fehrenbach S, Frebourg T, Pagani F, Tosi M, Martins A (2010) A rare SMN2 variant in a previously unrecognized composite splicing regulatory element induces exon 7 inclusion and reduces the clinical severity of spinal muscular atrophy. Hum Mutat 31(1):E1110–E1125. doi:10.1002/humu.21173

    Article  PubMed  Google Scholar 

  31. Hauke J, Riessland M, Lunke S, Eyupoglu IY, Blumcke I, El-Osta A, Wirth B, Hahnen E (2009) Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. Hum Mol Genet 18(2):304–317. doi:10.1093/hmg/ddn357

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank the patients and their families for their contribution to this study. This manuscript is dedicated to the memory of Dr. Goula Stylianidou.

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Christodoulou.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Theodorou, L., Nicolaou, P., Koutsou, P. et al. Genetic findings of Cypriot spinal muscular atrophy patients. Neurol Sci 36, 1829–1834 (2015). https://doi.org/10.1007/s10072-015-2263-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-015-2263-5

Keywords

Navigation